Are cell-derived microparticles generated in patients during cardiopulmonary bypass highly procoagulant?
This study is the first to demonstrate that microparticles generated in vivo can stimulate coagulation.
Two-thirds of 51 HCPS patients with a predicted mortality of 100%, who were supported with ECMO, survived and recovered completely. Survival was significantly higher in the second half of the study. Complications associated with both types of femoral cannulation were associated with a trend toward decreased survival, which was not significant.